NovaXS Biotech Corp (NovaXS), developers of an in-home and needle-free drug delivery platform, won first-place and was voted as Audience Favorite at the Berkeley SkyDeck Pad-13 Pitch Competition. NovaXS’s Founder and CEO Alina Su and her team provided a demonstration of their Telosis device which aims to provide an easy and painless alternative to administer drugs at home without needles to make healthcare more accessible.
“NovaXS Biotech is honored to be selected as the champions and audience favorite of the Berkeley SkyDeck Pitch Competition, especially out of all the impressive startups in attendance,” said Alina Su, CEO and Founder of NovaXS. “When my sister was younger, she was diagnosed with a disease that required daily needle injections for treatment. I witnessed her pain and the inefficiencies in self-administered drug delivery first-hand which is why me and my team are so dedicated to developing this solution.”
At the competition, NovaXS and eleven other startups in the technology, communications, healthcare, and other industries, showcased their products to SkyDeck advisors, mentors, alumni and investors. NovaXS was selected for its strong business potential and ability to transform healthcare delivery. The product prototype is a device that administers a narrow stream of medication without a needle and analyzes injection data. NovaXS is focused on making the drug delivery process a better experience for patients with diabetes, growth hormone deficiencies, allergies and IVF therapies.
“NovaXS Biotech strives to lower the barrier for healthcare access. We’re currently working on the FDA clearance to use our device and platform on the human body. Working with our SkyDeck mentors Cathy Farmer, Darren Cooke, Caroline Winnett and Sibyl Chen to refine our value proposition and provide industry insights is so valuable as we work toward our goals,” added Su.
NovaXS is a member of the Berkeley SkyDeck program and also won first place in the Berkeley Fall 2021 Collider Cup held by Berkeley Sutardja Center for Entrepreneurship and Technology. NovaXS Biotech is also enrolled in the mHub MedTech Accelerator, USC Troylabs and Newchip Accelerator.